China Colorectal Cancer Treatment Market In-Depth Outlook Size, Share & Major Stakeholders

How Big is the China Colorectal Cancer Treatment Market?

The China Colorectal Cancer Market is expecting around 3.5% CAGR during 2022-27. The growth of the market is driven primarily by the rising instances of colorectal cancer among people across China, coupled with the mounting consumer awareness about constant innovations in its treatment & diagnosis.

Market Statistics

  • Market Growth Rate (CAGR): 3.5% from 2022-2027

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure-  https://www.marknteladvisors.com/query/request-sample/china-colorectal-cancer-market.html

China Colorectal Cancer Treatment Market Segmentation:

The report has segmented the market into the following categories:

By Diagnosis

  1. Digital Rectal Examination
  2. Fecal Occult Blood Test
  3. Flexible Sigmoidoscopy
  4. Colonoscopy
  5. Virtual Colonoscopy
  6. Double Contrast Barium Enema

By Treatment

  1. Immunotherapy Drugs
    1. Monoclonal antibodies
      1. Bevacizumab
      2. Cetuximab
      3. Panitumumab
    2. Biologic Response Modifiers
    3. Colony-Stimulating Factors
    4. Tumor Vaccines
  2. Targeted Therapies
  3. Chemotherapy
    1. Alkylating agent
    2. Antimetabolites
      1. Fluorouracil
      2. Capecitabine
    3. Others
  4. Surgery
  5. Radiation Therapy

By Region

  1. North
  2. North-East
  3. North-West
  4. East
  5. South-West
  6. South Central

Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/china-colorectal-cancer-market.html

Competitive Landscape:

  • Amgen China
  • Bristol-Myers Squibb
  • Bayer AG
  • Merck KGaA
  • Roche (China) Co., Ltd.
  • Eli Lilly and Company
  • Sanofi China
  • Taiho Pharmaceutical
  • Novartis AG
  • Pfizer Inc.

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*

Key Highlights of the Report:

  • Market Performance (2022-2027)
  • Strategic Recommendations
  • Current, Historical and Future Market Trends
  • Market Drivers and Leading Competitor
  • SWOT Analysis
  • Structure of the Market
  • Comprehensive Mapping and Recent Advancement

Other Report:

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call +1 628 895 8081, +91 120 4278433

Email: [email protected]